Page last updated: 2024-09-03

tyrosyl-arginyl-phenylalanyl-lysinamide and Reperfusion Injury

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with Reperfusion Injury in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldsmith, JR; Jobin, C; Perez-Chanona, E; Roth, B; Whistler, J; Yadav, PN1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and Reperfusion Injury

ArticleYear
Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling.
    The American journal of pathology, 2013, Volume: 182, Issue:3

    Topics: Animals; Apoptosis; Cytoprotection; Enterocytes; Epithelial Cells; Gene Deletion; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Intestines; Ligands; Mice; Mice, Inbred C57BL; Oligopeptides; Organ Specificity; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Receptors, Opioid, mu; Reperfusion Injury; Signal Transduction

2013